Reply: Triage Considerations for Patients Referred for Structural Heart Disease Intervention During the Coronavirus Disease 2019 (COVID-19) Pandemic: An ACC/SCAI Consensus Statement
- PMID: 32646705
- PMCID: PMC7338009
- DOI: 10.1016/j.jcin.2020.05.035
Reply: Triage Considerations for Patients Referred for Structural Heart Disease Intervention During the Coronavirus Disease 2019 (COVID-19) Pandemic: An ACC/SCAI Consensus Statement
Comment on
-
TAVR During the COVID-19 Pandemic: The ACC/SCAI Consensus Statement.JACC Cardiovasc Interv. 2020 Jul 13;13(13):1605-1606. doi: 10.1016/j.jcin.2020.04.053. Epub 2020 May 3. JACC Cardiovasc Interv. 2020. PMID: 32646703 Free PMC article. No abstract available.
-
Performing Structural Heart Disease Interventions During the COVID-19 Pandemic: But What Are the Downsides?JACC Cardiovasc Interv. 2020 Jul 13;13(13):1606-1607. doi: 10.1016/j.jcin.2020.05.007. Epub 2020 May 12. JACC Cardiovasc Interv. 2020. PMID: 32646704 Free PMC article. No abstract available.
References
-
- Shah P.B., Welt F.G.P., Mahmud E. from the American College of Cardiology (ACC) and the Society for Cardiovascular Angiography and Interventions (SCAI). Triage considerations for patients referred for structural heart disease intervention during the coronavirus disease 2019 (COVID-19) pandemic: an ACC /SCAI position statement. J Am Coll Cardiol Intv. 2020;13:1484–1488. - PubMed
-
- Elbaz-Greener G., Maish S., Fang J. Temporal trends and clinical consequences of wait times for transcatheter aortic valve replacement: a population study. Circulation. 2018;138:483–493. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical